|
Volumn 20, Issue 27, 2001, Pages 3580-3584
|
Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner
a,b a c a |
Author keywords
Alkylation; Apoptosis; Cisplatin; Heterozygosity; Mismatch repair; Mutation
|
Indexed keywords
CISPLATIN;
GENE PRODUCT;
PROTEIN MSH 2;
UNCLASSIFIED DRUG;
ALLELE;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
BASE MISPAIRING;
CARCINOGENESIS;
CONTROLLED STUDY;
DNA DAMAGE;
DNA METHYLATION;
GENE DOSAGE;
GENE FREQUENCY;
GENE LOCUS;
GENE MUTATION;
GENE REPRESSION;
HETEROZYGOSITY;
HOMOZYGOSITY;
MOUSE;
MUTATION RATE;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
APOPTOSIS;
BASE PAIR MISMATCH;
CISPLATIN;
DNA REPAIR;
DNA-BINDING PROTEINS;
GENE DOSAGE;
GENOTYPE;
HETEROZYGOTE;
METHYLNITRONITROSOGUANIDINE;
MICE;
MICE, KNOCKOUT;
MUTAGENESIS;
MUTATION;
MUTS HOMOLOG 2 PROTEIN;
PROTO-ONCOGENE PROTEINS;
|
EID: 0035859002
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204449 Document Type: Article |
Times cited : (19)
|
References (24)
|